Literature DB >> 22950087

Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication.

Tauseef Ali1, Faiz Shakir, Jordan Morton.   

Abstract

Increased recognition of the limits of conventional medicine has helped drive the growing interest in complementary and alternative medicine which is now being commonly used in patients with chronic diseases, including individuals with Crohn's disease and ulcerative colitis. Recently, scientific interest has unraveled the beneficial pharmacological effects of curcumin. We present an updated concise review of currently available in vitro, animal and clinical studies demonstrating the therapeutic effect of herbal medication in inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22950087     DOI: 10.1159/000336720

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  15 in total

Review 1.  Autophagy: a new target or an old strategy for the treatment of Crohn's disease?

Authors:  Kris Nys; Patrizia Agostinis; Séverine Vermeire
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-16       Impact factor: 46.802

Review 2.  Chili Peppers, Curcumins, and Prebiotics in Gastrointestinal Health and Disease.

Authors:  Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  Curr Gastroenterol Rep       Date:  2016-04

Review 3.  Herbal and plant therapy in patients with inflammatory bowel disease.

Authors:  Aikaterini Triantafyllidi; Theodoros Xanthos; Apostolos Papalois; John K Triantafillidis
Journal:  Ann Gastroenterol       Date:  2015 Apr-Jun

Review 4.  Natural product-derived drugs for the treatment of inflammatory bowel diseases.

Authors:  Young-Eun Joo
Journal:  Intest Res       Date:  2014-04-29

5.  Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.

Authors:  Bo Xiao; Zhan Zhang; Emilie Viennois; Yuejun Kang; Mingzhen Zhang; Moon Kwon Han; Jiucun Chen; Didier Merlin
Journal:  Theranostics       Date:  2016-09-25       Impact factor: 11.556

6.  FLLL32, a curcumin analog, ameliorates intestinal injury in necrotizing enterocolitis.

Authors:  Jeffrey Eckert; Brian Scott; Shelley M Lawrence; Michael Ihnat; Hala Chaaban
Journal:  J Inflamm Res       Date:  2017-06-14

7.  Diarrhoea Management using Over-the-counter Nutraceuticals in Daily practice (DIAMOND): a feasibility RCT on alternative therapy to reduce antibiotic use.

Authors:  Yanhong Jessika Hu; Xudong Zhou; Shanjuan Wang; Merlin Willcox; Colin Garner; David Brown; Taeko Becque; Beth Stuart; Zongru Han; Qin Chang; Michael Moore; Paul Little
Journal:  Pilot Feasibility Stud       Date:  2021-06-15

8.  Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells.

Authors:  Min-Jung Park; Su-Jin Moon; Sung-Hee Lee; Eun-Ji Yang; Jun-Ki Min; Seok-Goo Cho; Chul-Woo Yang; Sung-Hwan Park; Ho-Youn Kim; Mi-La Cho
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

9.  Comparative absorption of curcumin formulations.

Authors:  Ralf Jäger; Ryan P Lowery; Allison V Calvanese; Jordan M Joy; Martin Purpura; Jacob M Wilson
Journal:  Nutr J       Date:  2014-01-24       Impact factor: 3.271

10.  Protective effects of curcumin against genotoxicity induced by 131-iodine in human cultured lymphocyte cells.

Authors:  Nayereh Shafaghati; Monireh Hedayati; Seyed Jalal Hosseinimehr
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.